Results 91 to 100 of about 6,404 (193)

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Herpes Zoster and Post-Herpetic Neuralgia—Diagnosis, Treatment, and Vaccination Strategies

Pathogens
Introduction: Herpes zoster is caused by the reactivation of latent varicella infection within the sensory ganglia, caused by the varicella-zoster virus (VZV).
Delwyn Zhi Jie Lim, Hong Liang Tey, Brenda Mae Alferez Salada, Jolene Ee Ling Oon, Ee-Jin Darren Seah, Nisha Suyien Chandran, Jiun Yit Pan   +6 more
doaj   +1 more source

Co-administration of the adjuvanted recombinant zoster vaccine with other adult vaccines: An overview

Vaccine
The adjuvanted recombinant zoster vaccine (RZV; Shingrix®, GSK) is a subunit vaccine that has been approved for the prevention of herpes zoster in adults. Co-administration of two vaccines in a single visit is a strategy to improve overall vaccine coverage.This review aims to consolidate available clinical data on RZV co-administration, providing an ...
S. Omar Ali, Christophe Dessart, Raunak Parikh   +2 more
openaire   +2 more sources

Prevention of Herpes Zoster in Chronic Kidney Disease

Giornale di Clinica Nefrologia e Dialisi
The varicella-zoster virus (VZV) is responsible for both primary varicella infection and Herpes Zoster (HZ), the latter resulting from viral reactivation in immunocompromised or elderly individuals.
Barbara Maresca, Giulia Conforti, Silvana Chicca, Marco Galliani   +3 more
doaj   +1 more source

The Herpes Zoster Patient Pathway and Gaps in Current Vaccination Guidelines in Southeast Asia: Summary of a Zoster Experts’ Network Scientific Workshop

Vaccines
The burden of herpes zoster (HZ) is recognized worldwide; however, there is seemingly limited information on incidence and vaccination practices in Southeast Asia (SEA).
Gyneth Lourdes G. Bibera, Peter San Martin, Desiree A. M. van Oorschot, Afif Nurul Hidayati, Deliana Permatasari, Sasheela Sri La Sri Ponnampalavanar, Kughan Govinden, Maria Christina Filomena Batac, Joselito Javier, Terapong Tantawichien, Phatu Boonmahittisut, Trinh Minh Trang, Thanh Tuyen Dang Thi   +12 more
doaj   +1 more source

ePoster

European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source

Herpes zoster reactivation in a cohort of people living with HIV vaccinated with recombinant vaccine

Vaccine
People living with HIV (PLWH) have a higher risk of herpes zoster (HZ) reactivation and postherpetic neuralgia (PHN) compared to general population. Our study aims to evaluate prevalence of HZ reactivation and PHN after vaccination with recombinant vaccine (RZV) in a population living with HIV, and to identify risk factors associated with recurrence.We
Arsuffi S., Rossi L., Colombo F. R., Inverardi M., Mirovic E., Laurenda D., Izzo I., Rapino S., Castelli D., Gaffurini F., Polesini I., Castelli F., Calza S., Quiros-Roldan E., Foca' Emanuele   +14 more
openaire   +3 more sources

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis

, 2019
BACKGROUND: The adjuvanted recombinant zoster vaccine (Shingrix) can prevent herpes zoster in older adults and autologous haemopoietic stem cell transplant recipients.
Lee J. -J., Young J. -A., Pullon H., Sultan F., Wang P. -N., Lee W. -S., Johnston A., Sohn S. K., Chiou T. -J., Mullane K., Yanez San Segundo L., Selleslag D., Quiel D., McNeil S. A., Pauksens K., Dagnew A. F., de la Serna J., Van den Steen P., Rodon P., Masood A., Miranda Castillo A. C., Homenda W., Heineman T. C., Perez de Oteyza J., Guillaume T., Oostvogels L., Mir N., Hwang W., Grosicki S., Zaja F., Anttila V. -J., Di Paolo E., Disperati P., Lucchesi A., Lopez-Fauqued M., Schattner A., Lee D. -G., Quittet P., Bowcock S., Gaidano G., Kwak J. -Y., Navarro Matilla M. B., Kuo C. -Y., Schuind A., Kim S. J., Blesing N., Eek R., Eom H., Woszczyk D., Sanmartin Berglund J., Rodriguez Macias G., Aoun M., Murphy J., Campora L., El Idrissi M., Barba Sunol P., Kuvshinov A., Comeau T., Salaun B., Lie A. K. -W., Peniket A., Pohlreich D., Acar K., Myasnikov A., Alonso Alonso A., Turner P., Rombo L., Zachee P., Ilyin N., Lee J. H., Lepretre S., del Campo T., Afanasyev B., Ilhan O., Theunissen K., Milliken S., Ona Navarrete R., Samoylova O., Sinisalo M.   +78 more
core   +1 more source

Cost-effectiveness analysis of herpes zoster vaccination for adults aged 50 years in Zhejiang province, China

Frontiers in Public Health
ObjectiveLive-attenuated zoster vaccine (LZV) and adjuvanted recombinant zoster vaccine (RZV) have been approved for use in China. This study aimed to evaluate and compare the cost-effectiveness of these two herpes zoster (HZ) vaccination strategies in a
Fuxing Chen, Linglin Ding, Yu Hu
doaj   +1 more source

Recombination of globally circulating Varicella Zoster Virus

, 2015
Varicella zoster virus (VZV) is a human herpesvirus, which during primary infection typically causes varicella (chickenpox) and establishes lifelong latency in sensory and autonomic ganglia. Later in life, the virus may reactivate to cause herpes zoster (
Norberg, Peter,, Bergstrom, T., Breuer, J., Tang, J., Tang, J. W., Grahn, Anna,, Hussaini, Y., Underhill, G. S., Koay, E. S. C., Depledge, D. P., Brown, J., Bergström, Tomas,, Molyneaux, P., MacMohan, E., Kundu, S., Studahl, Marie,, Haque, T., Grahn, A., Norberg, P., Sengupta, N., Underhill, G., Atkinson, C., Studahl, M., Depledge, D., Koay, E., MacMahon, E., Papaevangelou, V.   +26 more
core   +1 more source